NCT04871841View on ClinicalTrials.gov

Study of Sputnik V COVID-19 Vaccination in Adults in Kazakhstan

CompletedOBSERVATIONAL
Enrollment

82

Participants

Timeline

Start Date

April 5, 2021

Primary Completion Date

September 5, 2021

Study Completion Date

June 20, 2023

Conditions
Covid19Vaccine Adverse Reaction
Interventions
BIOLOGICAL

Sputnik V

Participants will receive intramuscular (IM) injection of a single dose of rAd26-S and rAd5-S at day 0 and day 21, respectively.

Trial Locations (1)

100008

Karaganda Medical University, Karaganda

All Listed Sponsors
collaborator

McMaster University

OTHER

lead

Karaganda Medical University

OTHER

NCT04871841 - Study of Sputnik V COVID-19 Vaccination in Adults in Kazakhstan | Biotech Hunter | Biotech Hunter